Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia

This article discusses case reports of treatment with paliperidone palmitate in comparison with data from recent publications. Second-generation long-acting injectable antipsychotics have been shown to provide better control of psychiatric manifestations, reduce the severity of negative symptoms, im...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Natalia N. Petrova, Valeria S. Serazetdinova
Formato: article
Lenguaje:EN
RU
Publicado: Eco-Vector 2020
Materias:
Acceso en línea:https://doaj.org/article/110daf009b524851b3d43a62eb14fc96
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:110daf009b524851b3d43a62eb14fc96
record_format dspace
spelling oai:doaj.org-article:110daf009b524851b3d43a62eb14fc962021-12-02T17:38:43ZLong-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia2712-76722713-291910.17650/2712-7672-2020-1-2-53-62https://doaj.org/article/110daf009b524851b3d43a62eb14fc962020-12-01T00:00:00Zhttps://www.consortium-psy.com/jour/article/viewFile/52/15https://doaj.org/toc/2712-7672https://doaj.org/toc/2713-2919This article discusses case reports of treatment with paliperidone palmitate in comparison with data from recent publications. Second-generation long-acting injectable antipsychotics have been shown to provide better control of psychiatric manifestations, reduce the severity of negative symptoms, improve social functioning and quality of life of patients and relatives, and reduce the burden of disease for both the healthcare system and the caregivers. The case reports presented in this article demonstrate better quality of remission in schizophrenia patients treated with one- monthly and three-monthly paliperidone palmitate formulations, due to higher effi in preventing relapses, better safety and good tolerability regardless of patient age.Natalia N. PetrovaValeria S. SerazetdinovaEco-Vectorarticlepaliperidone palmitateschizophrenialong-acting injectablepersonal recoveryPsychiatryRC435-571PsychologyBF1-990ENRUConsortium Psychiatricum, Vol 1, Iss 2, Pp 53-62 (2020)
institution DOAJ
collection DOAJ
language EN
RU
topic paliperidone palmitate
schizophrenia
long-acting injectable
personal recovery
Psychiatry
RC435-571
Psychology
BF1-990
spellingShingle paliperidone palmitate
schizophrenia
long-acting injectable
personal recovery
Psychiatry
RC435-571
Psychology
BF1-990
Natalia N. Petrova
Valeria S. Serazetdinova
Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia
description This article discusses case reports of treatment with paliperidone palmitate in comparison with data from recent publications. Second-generation long-acting injectable antipsychotics have been shown to provide better control of psychiatric manifestations, reduce the severity of negative symptoms, improve social functioning and quality of life of patients and relatives, and reduce the burden of disease for both the healthcare system and the caregivers. The case reports presented in this article demonstrate better quality of remission in schizophrenia patients treated with one- monthly and three-monthly paliperidone palmitate formulations, due to higher effi in preventing relapses, better safety and good tolerability regardless of patient age.
format article
author Natalia N. Petrova
Valeria S. Serazetdinova
author_facet Natalia N. Petrova
Valeria S. Serazetdinova
author_sort Natalia N. Petrova
title Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia
title_short Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia
title_full Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia
title_fullStr Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia
title_full_unstemmed Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia
title_sort long-acting injectable drugs in the maintenance therapy of patients with schizophrenia
publisher Eco-Vector
publishDate 2020
url https://doaj.org/article/110daf009b524851b3d43a62eb14fc96
work_keys_str_mv AT natalianpetrova longactinginjectabledrugsinthemaintenancetherapyofpatientswithschizophrenia
AT valeriasserazetdinova longactinginjectabledrugsinthemaintenancetherapyofpatientswithschizophrenia
_version_ 1718379809621409792